JPMORGAN CHASE & CO - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q3 2016$4,632,000
+96.0%
37,208
+80.2%
0.00%0.0%
Q1 2016$2,363,000
-33.5%
20,644
-33.1%
0.00%0.0%
Q2 2015$3,552,000
-42.8%
30,844
-52.6%
0.00%0.0%
Q1 2015$6,214,000
+2095.8%
65,056
+1142.9%
0.00%
Q3 2014$283,0005,2340.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Segantii Capital Management Ltd 50,000$5,288,0005.80%
RUDMAN ERROL M 37,001$3,934,0003.76%
INDUS CAPITAL PARTNERS, LLC 349,210$37,128,0003.60%
WARBURG PINCUS LLC 1,312,200$139,513,0003.04%
SPQ Asia Capital Ltd 96,000$10,206,0002.63%
OBERWEIS ASSET MANAGEMENT INC/ 82,775$8,801,0002.62%
Ativo Capital Management LLC 94,074$10,002,0002.44%
Sensato Investors LLC 99,764$10,607,0001.72%
Cormorant Asset Management, LP 112,867$12,000,0001.70%
BARING ASSET MANAGEMENT Ltd 131,284$13,958,0001.14%
View complete list of CHINA BIOLOGIC PRODS INC shareholders